Skip to main content
  • Explore a Treatment Option
  • About MIND-TD
  • Explore a Treatment Option
  • About MIND-TD
Site logo

The MIND-TD Faculty have been compensated by Neurocrine Biosciences, Inc.

  • Home
  • Symptoms of TD
    • Screening & Diagnosis
    • Differential Diagnosis
  • TD Treatment
  • Library
  • Explore a Treatment Option
  • About MIND-TD
  • Explore a Treatment Option
  • About MIND-TD
Back to the Library

Tardive Dyskinesia Differential Diagnosis Slide Library

  • Leslie Citrome, MD, MPH
  • Robert A. Hauser, MD, MBA, FAAN
  • Tammy J. LeBlanc-Russo, NP
  • Stephen M. Stahl, MD, PhD, DSc (Hon)

Presentation

•

10+ mins

•

Dec 2024

Download
Copy Link Share via Email Share via SMS
1

1 of 62

Related Resources


  • Download

    •

    ~1 min

    •

    Dec 2022


    Tardive Dyskinesia Differential Diagnosis Poster
  • Podcast

    •

    ~3 mins

    •

    Feb 2022


    "We Need to Look, We Need to Ask." Spotting Tardive Dyskinesia in Practice
  • Video

    •

    10+ mins

    •

    Jan 2025


    A Modified Delphi Consensus Study of the Screening, Diagnosis, and Treatment of Tardive Dyskinesia
Neurocrine Biosciences Logo

©2025 Neurocrine Biosciences, Inc. All Rights Reserved.

  • Privacy Policy
  • Cookie Policy
  • Terms & Conditions
  • Accessibility
  • Site Map

CP-TD-US-1751 04/25

The MIND-TD website and educational content were sponsored and co-developed by Neurocrine Biosciences, Inc. The faculty have been compensated by Neurocrine Biosciences. This non-CME program is intended to provide general information about tardive dyskinesia and not medical advice for any particular patient.

You are about to leave this website

Leave Site

By continuing to use this site, you agree to our use of cookies as described in our Cookie Policy.

This site contains information intended only for US healthcare professionals involved in the management of people with tardive dyskinesia.

This website is part of a disease-awareness, non-CME program sponsored by Neurocrine Biosciences, Inc.